Stefanie Harlfinger

Toxicokinetics of Acrylamide in Humans after Ingestion of a Defined Dose in a Test Meal to Improve Risk Assessment for Acrylamide Carcinogenicity

Uwe Fuhr, Melanie I. Boettcher, Martina Kinzig‐Schippers et al. · Cancer Epidemiology Biomarkers & Prevention · 2006 · 179 citations

Defined Dose, Acrylamide Carcinogenicity, Dietary Exposure +14

Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers

Emilie A. Chapeau, Laurent Sansregret, Giorgio Giacomo Galli et al. · Nature Cancer · 2024 · 104 citations · Full text

Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach

Edwige Lorthiois, James Roache, David Barnes‐Seeman et al. · Journal of Medicinal Chemistry · 2020 · 22 citations · Full text

Sensitive and convenient method for the quantification of clonidine in serum of pediatric patients using liquid chromatography/tandem mass spectrometry

Carsten Müller, Milica Ramić, Stefanie Harlfinger et al. · Journal of Chromatography A · 2006 · 19 citations

Medicine, Bioanalysis, Mass Spectrometry +10

Quantification of mephenytoin and its metabolites 4′‐hydroxymephenytoin and nirvanol in human urine using a simple sample processing method

Tobias Klaassen, Dirk Kasel, Stefanie Harlfinger et al. · Rapid Communications in Mass Spectrometry · 2004 · 10 citations

Gas Chromatography, Bioanalysis, Triple-stage Mass Spectrometry +20